NGNE
NGNE
NASDAQ · Biotechnology

Neurogene Inc

$17.23
+0.86 (+5.25%)
As of Feb 8, 2:01 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 64.19M 65.56M 69.77M
Net Income 8.40M 8.13M 10.74M
EPS
Profit Margin 13.1% 12.4% 15.4%
Rev Growth +4.7% +24.1% +24.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 117.21M 111.57M 122.33M
Total Equity 131.11M 140.60M 129.06M
D/E Ratio 0.89 0.79 0.95
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 15.55M 13.35M 15.74M
Free Cash Flow 10.13M 9.92M 11.85M